These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17698633)

  • 1. Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome.
    Chase A; Grand FH; Cross NC
    Blood; 2007 Nov; 110(10):3729-34. PubMed ID: 17698633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
    Landberg N; Dreimane A; Rissler M; Billström R; Ågerstam H
    Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
    Malli T; Buxhofer-Ausch V; Rammer M; Erdel M; Kranewitter W; Rumpold H; Marschon R; Deutschbauer S; Simonitsch-Klupp I; Valent P; Muellner-Ammer K; Sebesta C; Birkner T; Webersinke G
    Genes Chromosomes Cancer; 2016 Jan; 55(1):60-8. PubMed ID: 26391436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion.
    Qiu XH; Li F; Cao HQ; Shao JJ; Mei JG; Li HQ; Zhai YP
    Mol Med Rep; 2017 Mar; 15(3):1024-1030. PubMed ID: 28138694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.
    Agerstam H; Järås M; Andersson A; Johnels P; Hansen N; Lassen C; Rissler M; Gisselsson D; Olofsson T; Richter J; Fan X; Ehinger M; Fioretos T
    Blood; 2010 Sep; 116(12):2103-11. PubMed ID: 20554971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.
    Dong S; Kang S; Gu TL; Kardar S; Fu H; Lonial S; Khoury HJ; Khuri F; Chen J
    Blood; 2007 Jul; 110(1):360-9. PubMed ID: 17389761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.
    Chase A; Bryant C; Score J; Cross NC
    Haematologica; 2013 Jan; 98(1):103-6. PubMed ID: 22875613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).
    Wasag B; Lierman E; Meeus P; Cools J; Vandenberghe P
    Haematologica; 2011 Jun; 96(6):922-6. PubMed ID: 21330321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.
    Zhang WW; Habeebu S; Sheehan AM; Naeem R; Hernandez VS; Dreyer ZE; López-Terrada D
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):879-83. PubMed ID: 19829149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report.
    Wang Y; Wu X; Deng J; Yu H; Xu R; Zhu Z; Tu S; Hu Y
    Cancer Biol Ther; 2016 Aug; 17(8):785-9. PubMed ID: 27415155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
    Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
    Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
    Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
    Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of a patient characterized by t(8;22)(p11;q11) and BCR/FGFR1 fusion gene, who was successfully treated with haploidentical hematopoietic stem cell transplantation.
    Chen X; Huang L; Zheng C; Wang Z
    Hematology; 2021 Dec; 26(1):691-696. PubMed ID: 34493159
    [No Abstract]   [Full Text] [Related]  

  • 15. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins.
    Demiroglu A; Steer EJ; Heath C; Taylor K; Bentley M; Allen SL; Koduru P; Brody JP; Hawson G; Rodwell R; Doody ML; Carnicero F; Reiter A; Goldman JM; Melo JV; Cross NC
    Blood; 2001 Dec; 98(13):3778-83. PubMed ID: 11739186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1.
    Yamamoto S; Otsu M; Matsuzaka E; Konishi C; Takagi H; Hanada S; Mochizuki S; Nakauchi H; Imai K; Tsuji K; Ebihara Y
    PLoS One; 2015; 10(3):e0120841. PubMed ID: 25803811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1.
    Heath C; Cross NC
    J Biol Chem; 2004 Feb; 279(8):6666-73. PubMed ID: 14660670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 8p11 myeloproliferative syndrome owing to rare FGFR1OP2-FGFR1 fusion.
    Onozawa M; Ohmura K; Ibata M; Iwasaki J; Okada K; Kasahara I; Yamaguchi K; Kubota K; Fujisawa S; Shigematsu A; Endo T; Kondo T; Hashino S; Tanaka J; Matsuno Y; Asaka M; Imamura M
    Eur J Haematol; 2011 Apr; 86(4):347-9. PubMed ID: 21198859
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
    Morishige S; Oku E; Takata Y; Kimura Y; Arakawa F; Seki R; Imamura R; Osaki K; Hashiguchi M; Yakushiji K; Mizuno S; Yoshimoto K; Nagafuji K; Ohshima K; Okamura T
    Acta Haematol; 2013; 129(2):83-9. PubMed ID: 23171834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [8p11 myeloproliferative syndrome with CEP110-FGFR1 fusion in a patient].
    Chao H; Chen S; Zhou M; Lu X; Zhang X; Pan J; Wu C; Zhang R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):679-82. PubMed ID: 26418991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.